Changing Healthcare Forever mycopd

Similar documents
The product website contains useful information and videos that cover both the patient and the clinician interfaces for mycopd

Changing Healthcare Forever. myheart

Commissioning for Better Outcomes in COPD

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Rosemary Plum Prescriptive Solutions Ltd SIMPLE Respiratory 2015

Design - Multicentre prospective cohort study. Setting UK Community Pharmacies within one CCG area within the UK

Towards tailored and targeted asthma self-management using mobile technologies

National COPD Audit Programme

SCHEDULE 2 THE SERVICES. A. Service Specifications

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Care Bundle. Adult patients with COPD

Practical advice on smoking cessation: Patients with long-term conditions

Yorkshire & Humber Respiratory Programme Report

Chronic Obstructive Pulmonary Disease (COPD) Measures Document

LEARNING OBJECTIVES FOR COPD EDUCATORS

Yorkshire & Humber Respiratory Programme Report

NEBULISERS AND NEBULISED MEDICATION. A Guide for the use of nebulisers and nebulised medication in the community setting

Yorkshire & Humber Respiratory Programme Report

THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable

Yorkshire & Humber Respiratory Programme Report. NHS Hambleton, Richmondshire and Whitby Clinical Commissioning Group

Respiratory disease is the poor relation of the big three.

Bronchodilator Delivery and Nebuliser Trials in Adults

2017 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members

2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members

INITIATING A COPD CLINIC: PROTOCOL & ASSESSMENT

Algorithm for the use of inhaled therapies in COPD

Use of mobile health to improve patient adherence to the management of chronic obstructive pulmonary disease

Improving access to pulmonary rehabilitation through Medicare Benefit Scheme subsidies

QOF indicator area: Chronic Obstructive Pulmonary disease (COPD)

The links between physical health in mental health

Chronic Obstructive Pulmonary Disease (COPD).

An Outcomes Strategy for COPD and Asthma: NHS Companion Document IMPACT REPORT

Number of records submitted: 14,750 Number of participants: Part 1 = 146 hospitals (120 trusts); Part 2 = 140 hospitals (119 trusts)

Chronic obstructive pulmonary disease

CARE OF THE ADULT COPD PATIENT

Primary Care Standards Managing Asthma in Children & Young People

Introduction to Wessex AHSN Cathy Rule Project Manager Alcohol Quality Improvement Programme. 25 th June 2014

Algorithm for the use of inhaled therapies in COPD Version 2 May 2017

An Oncology Digital Companion for Patient-Reported Outcomes with Electronic Health Record Integration. Dr Zachary Tan

Diabetes education: the big missed opportunity in diabetes care? Phaedra Perry Regional Head South West Katherine Calder Senior Policy Officer

MYAIRCOACH NEWSLETTER

Using Pay-for-Performance to Improve COPD Care MHC64474 SV64474

Managing Exacerbations of COPD (Version 3.0)

Wales Primary Care COPD Audit

Policy position statement Chronic Obstructive Pulmonary Disease (COPD) May 2017 Introduction

National COPD Audit Programme

E1. Post hospital discharge follow-up services and rehabilitation programmes

Chronic Obstructive Pulmonary Disease. Information about medication and an Action Plan to use if your condition gets worse due to an infection

Planning for delivery in 15/16 for the Dementia and IAPT Ambitions

Better community respiratory care. Dr Roland Meyer Respiratory Physician Southern DHB August 2010

SABA: VENTOLIN EVOHALER (SALBUTAMOL) SAMA: ATROVENT IPRATROPIUM. Offer LAMA (discontinue SAMA) OR LABA

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG

Putting NICE guidance into practice. Resource impact report: Asthma: diagnosis, monitoring and chronic asthma management (NG80)

A NEBULISERS AND NEBULISED MEDICATION. Generic Guide for the use of nebulisers and nebulised medication

Community Pharmacy Asthma Audit 2016/17. Contents

Quality Improvement Tool Instruction Guide GRASP-COPD

Self-management plan for COPD

Helping Smokers Quit Clinicians adding value from every contact by treating tobacco dependence

Leeds West CCG Paediatric asthma project. January 2015-January 2017

Chronic Obstructive Pulmonary Disease (COPD)

ACO Impact on Transitions of Care: Witnessing the Improved Value of Re Engineering Communication at All Points of Care

Patient information leaflet. A study of low dose theophylline in Chronic Obstructive Pulmonary Disease (COPD)

NHS public health functions agreement Service specification No.11 Human papillomavirus (HPV) programme

A breath of fresh air

Pulmonary Rehab Sheffield Community Active Programmes Team. Ursula Freeman Physiotherapist and Team Leader

Prescribing guidelines: Management of COPD in Primary Care

COPD in primary care: reminder and update

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer

Chronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines

HIGH BLOOD PRESSURE. How can we do better?

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

Asthma and Respiratory Foundation NZ. Teresa Demetriou, Hayley Sims, Vanessa Searing

Networking for success: A burning platform in Berkshire West

Objectives. Context. Wider NHS context 5/24/2017. Technology in palliative care. Technology enabled Care (TEC)

Hull and East Riding. Chronic Obstructive Pulmonary. Disease (COPD) Equity Audit

Dementia Strategy MICB4336

LUNGS IN ACTION: Maintaining Exercise Capacity in Clients with COPD Post Completion of Pulmonary Rehabilitation

London Strategic Clinical Networks. Quality Standard. Version 1.0 (2015)

GOVERNING BODY REPORT

Enhanced CPD Programme Module 1. Introducing Starting Well

MULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient

GDm-Health is free to download and use. Its use may result in efficiency savings from reducing face-to-face clinic appointments.

Allwin Mercer Dr Andrew Zurek

Los Angeles PRISMS Center

Bridges to Excellence Chronic Obstructive Pulmonary Disease Care Recognition Program Guide

Managing COPD. Richard EK Russell Imperial College London, UK. Paul A Ford Imperial College London, UK

Cancer Awareness & Early Diagnosis Project Examples. Location: Camden (intervention area) and Kensington & Chelsea (control area), London

Roflumilast (Daxas) for chronic obstructive pulmonary disease

호흡재활치료 울산의대서울아산병원 호흡기내과 이상도

ehealth (Telemedicine) and concepts of virtual clinical trials Prof. Dr. med. Siegfried Jedamzik Berlin, 09. November 2017

Chronic Obstructive Pulmonary Disease, shortened to COPD, is an umbrella term for a group of conditions which cause long-term damage to the airways.

PCRS-UK briefing document Asthma guidelines. November 2017

NHS TAYSIDE RESPIRATORY MANAGED CLINICAL NETWORK BOARD TAYSIDE RESPIRATORY MANAGED CLINICAL NETWORK: ANNUAL REPORT

Health Professional Manual

2010 National Audit of Dementia (Care in General Hospitals) Guy's and St Thomas' NHS Foundation Trust

Cancer Transformation Programme

Fact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD)

Smoking cessation interventions and services

private patients centre stop smoking clinic Royal Brompton Hospital London

Transcription:

Changing Healthcare Forever mycopd

Introducing mycopd, from my mhealth. mycopd is the most comprehensive, user friendly and intuitive COPD App available on any device. Built by COPD experts, and externally peer reviewed by leading NHS COPD consultants and teams, mycopd puts patients, and their clinical team in control like never before. mycopd empowers patients to manage their COPD for a lifetime. Based on best evidence and national guidelines, mycopd provides 24-hour self-management, expert advice and support for patients with COPD. Unlike other COPD Apps, mycopd contains the first expert led, structured online education course for patients. In addition, mycopd assists patients in monitoring symptoms, lung function, using a COPD self-management plan, and understanding how to take their inhaled medication and rescue packs correctly. mycopd in clinical studies has been shown to: Correct between 80-98% of inhaler errors, present in over 70% of patients Deliver pulmonary rehabilitation (PR) with the same outcomes as face-to-face programs Reduce the rate of COPD exacerbations Double the rate of recovery from an acute exacerbation Significantly reduce the readmission rate compared to usual care in patients admitted with COPD The mycopd clinical software brings patients closer to their clinicians, enhancing and enabling efficient care remotely.

At just 20 per patient, for a lifetime, mycopd is the most cost-effective and complete digital intervention currently available for the condition, improving outcomes, and efficiency across the entire patient pathway.

Why does healthcare need mycopd? Self-management is considered by current COPD guidelines to be an essential component in the management of the condition and is recommended with the highest level of evidence. Indeed, in some studies collaborative selfmanagement has been shown to reduce admissions by almost 40% 1. Evidence shows that when quality interventions are offered, self-management education results in an improvement in adherence to therapy, and in most cases, COPD outcomes. Unfortunately, outside of pulmonary rehabilitation (PR), COPD education is still insufficiently integrated into standard COPD care provision. Of the patients referred into PR: 30% do not attend initial assessment Only 42% complete the 6-week course At best only 2.3% of patients with COPD in the UK complete PR each year 2. This is unlikely to improve in the near future as current services have dropped from 230 to 193 due to reduced staffing, and 2 in 5 patients are waiting more than 90 days to enrol into the programme 3. mycopd not only delivers to the patient an individualised, comprehensive COPD education program, it also provides a suite of tools to enable efficient self-management and rehabilitation, at a time and place to suit the patient. This improves patient outcomes and reduces the burden on clinical services.

mycopd also helps with the delivery of clinical services, at all levels of care to patients using our clinical management software. Clinicians are able to deliver enhanced patient centred services, often remotely, to many more patients than traditional care models. In fact, in clinical studies in primary care, mycopd has been shown to reduce the burden of delivering the annual review by 75%, because many of the processes are automated, for example: disease education, inhaler/ spacer instruction and assessment of symptoms using validated tools. mycopd provides an innovative enhancement to classical face-to-face consultations, bringing together patient-reported data, alongside clinical data e.g. FEV1, Spirometry - improving patient outcomes, clinician efficiency and work flows.

Facts about COPD. 1.2 million people in the UK have been diagnosed with COPD. 4.5% of all people over the age of 40 live with COPD. 27% There are 27% more people diagnosed with COPD than 10 years ago. 115,000 patients are newly diagnosed each year. Inhaler device errors are present in up to 90% of patients with COPD reducing the effectiveness of the drug.

Why my mhealth? my mhealth are perfectly positioned to help the NHS meet the pressing need to improve efficiencies and outcomes in the management of long term conditions. We create Apps which empower patients through digital selfmanagement and enable remote service delivery by clinicians at both an individual and a population scale. Our Apps are MHRA certified and operate under strict clinical (SCCI 0129) and information governance (IGT Level 2 compliant) frameworks. In addition, we also offer our expert led Digital Transformation Team service to aid deployment and help co-design patient pathways. We are currently working in over 70 CCGs in England, integrating Apps into patient pathways, transforming care and improving outcomes. Who is mycopd for? mycopd has been designed by clinical experts to benefit all patients at any stage of disease. mycopd clinical software assists and supports clinical teams at all levels, from primary to secondary care, and in rehabilitation services.

What does mycopd do for Patients? We believe that people should be supported to be as independent and healthy as possible; thereby preventing complications, and the need to go into hospital. mycopd gives patients 24/7 access to a range of powerful tools to educate, optimise self-management, monitor symptoms, and improve both their adherence and quality of inhaler administration. The key features are: Inhaler technique training Patients learn how to take their inhalers correctly using our unique set of inhaler videos. mycopd contains videos for every inhaler device (and spacer). Access to these has been shown to correct up to 98% of inhaler errors. Prescription assessment The patient will have access to a prescription assessment function which checks to see if there are conflicts within inhaled medication prescribed, that the prescription conforms to best evidence, and makes sure that the right spacer device is prescribed for the right inhaler. Self-Management Plan The mycopd self-management plan helps patients understand what medication to take and when. The self-management plan can be customised to the individual patient by the clinical team. Pulmonary Rehabilitation mycopd has a full 6-week rehabilitation program. Developed with leading rehabilitation experts, the mycopd PR program has been shown in a randomised controlled trial against standard class-based programs, to offer the same outcomes in improving 6-minute walk test and CAT scores 4.

Symptom and assessment tracking mycopd collects patient daily symptoms, and every few weeks, patients complete a COPD assessment test (CAT). On completion of the CAT, patients are presented with advice about how this can be improved. Results are stored in a report, so patients (and clinicians) can keep track of how well symptoms are controlled over time. Weather and air pollution forecasting Weather and pollution can impact on symptoms. Patients can view the latest reports and guidance based on their current location. Lung function mycopd helps patients keep track of their lung function (FEV1 and FVC) and spirometry. This function also assists clinical teams to monitor patients and access spirometry at a time when they most need it e.g. during a ward round, a key recommendation from the National COPD Audit 5. Patients with co-morbidities can access through the same login, other Apps from the my mhealth family, e.g. if they also suffer with diabetes or heart disease. This addresses the need to manage co-morbidities optimally to improve the patient s long term outcomes (a separate purchase is necessary for patients to access the other Apps).

Empowerment and Education mycopd contains expert education on all aspects of COPD. This high-quality content has been produced in-house, and externally peer reviewed by COPD experts to make sure patients receive the most up to date, and evidence-based education. Each patient education course is constructed based on the severity of COPD, treatment regime and symptoms. The progress through the course can be viewed by both patients and clinicians in the COPD checklist. Examples of the many education topics covered include : Anatomy of the lungs and Pacing what is COPD Oxygen Exercise and COPD Chest clearance Smoking cessation Exacerbations Breathlessness Anxiety and depression Medication and treatment Nutrition Sex and breathlessness Travelling Self-management Benefits Weather Pollution In addition to the education, self-management is achieved through a range of other tools provided in mycopd. These include: Medication Diary COPD checklist Keeps track of the health checks the patient needs to keep them well. These include tracking progress through the education course, CAT and inhaler instruction. Mindfulness and anxiety instruction Chest clearance instruction Oxygen alert card

What about clinicians? mycopd has been developed to help you manage your individual patients and your patient population, enabling you to identify those patients most at need. Using mycopd enables clinicians to deliver services to many more patients than previously possible in traditional settings. When you first login to mycopd you will see your COPD patient list. Unlike other systems, mycopd facilitates the prioritisation of patients most at need by using captured metrics such as symptoms reported or CAT scores mycopd mycopd mycopd This COPD patient checklist enables you to view which patients require certain checks to complete their annual review. Clicking on the patient name, in the patient list brings up the patient profile page which enables you to view at a glance individual patient s checklists, medication and demographics. From this page you can access the complete set of patient reports, change medication, upload spirometry, view trends in lung function and even contact the patient by sending a message through notifications. All changes made from the clinician interface update the patient s App, instantly! For example, changing a patient s inhaler/device will instantly change the patient s medication diary, self-management plan and inhaler videos.

Having access to the patient profile enables you to view their COPD control over time There are many more functions that facilitate care for your COPD patients: Assess the patient prescription against current guidelines Write and store consultations Set up appointments Customise the patient self-management plan Through the App you can send messages to individual patients, identified patient groups or broadcast health messages to your patients for free. Also, any changes you make to the patient record e.g. change of medication, will be sent automatically to your patient in their notification tile, and update their App. For example, changing an inhaler or device will automatically update the patient inhaler videos, self-management plan and medication diary instantly.

How can pulmonary rehab services use mycopd? Pulmonary rehabilitation is an integral part of COPD management, but many patients find it difficult to access, and 2 out of 5 patients are waiting longer than 90 days to enroll onto the program. The current capacity in the system means that only just over 2% of COPD patients complete a program each year. How does mycopd improve and augment the current pulmonary rehabilitation model? Provides access to patients who cannot attend class-based rehabilitation. Supports home-based exercises between standard classes. As a maintenance exercise and education program following completion of the course. Optimises other areas of self-management not supported by current services. From our experience integrating mycopd within pulmonary rehab services across the UK, providing patients with a hybrid model, supported by a digital tool, enables services to reach 5-10 times as many patients than previously possible. mycopd mycopd mycopd How do you get mycopd? For further information, please email info@mymhealth.com or call us on 01202 299583

Meet our COPD expert. Meet our COPD expert Prof Tom Wilkinson (Professor of Respiratory Medicine, University Hospital Southampton). Tom trained in medicine at Cambridge University and was appointed as Professor of Respiratory Medicine in 2016. Prof Tom Wilkinson is a world-renowned researcher and key opinion leader in the field of COPD and works in both hospital and community COPD services across Southampton City. Tom has won several national and international awards and was recognised by the European Respiratory Society as the leading researcher in Europe in his field under the age of 45. References; 1. Bourbeau J, Julien M, Maltais F, Rouleau M, et al.; Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Sante du Quebec. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163:585 591. 2. National Chronic Obstructive Pulmonary Disease Audit, 2015. 3. PCRS National Audit 2018. 4. Bourne S, DeVos R, North M, et al Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial BMJ Open 2017;7:e014580. doi: 10.1136/bmjopen-2016-014580 5. Royal College of Physicians - COPD: Time to integrate care organisational audit 2017.

my mhealth Limited 8 Trinity 161 Old Christchurch Road Bournemouth BH1 1JU Email: info@mymhealth.com 2018 my mhealth Limited.